Form 4 for BSX Boston Scientific
Accepted 2023-10-17 00:00:00 ET · period of report 2023-10-16 · accession 0001225208-23-009538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-17 | 2023-10-16 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale+OE | $49.79 | -11.7K | 51.8K | -18% | -$581.1K |
| DM | 2023-10-17 | 2023-10-16 | BSX | Carruthers Wendy | EVP, Human Resources | M - OptEx | $14.82 | +6,408 | 63.5K | +11% | +$95.0K |
| DM | 2023-10-17 | 2023-10-16 | BSX | Carruthers Wendy | EVP, Human Resources | M - OptEx | $0.00 | -6,408 | 5,919 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-16 | S | D | 11,671 | $49.79 | 51,795 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $49.52 to $50.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-10-16 | M | A | 3,448 | $16.31 | 60,506 | D | — | — | |
| 3 | Common | Common Stock | 2023-10-16 | M | A | 2,960 | $13.08 | 63,466 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-10-16 | M | D | 3,448 | $0.00 | 6,898 | D | $16.31 · — to 2025-02-23 | 3,448 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-10-16 | M | D | 2,960 | $0.00 | 5,919 | D | $13.08 · — to 2024-02-24 | 2,960 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |